Fintel reports that on March 18, 2025, RBC Capital initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform ...

Tetracycline should not be administered to patients younger than 8 years old ... Low-dose corticosteroids (such as dexamethasone, 0.125-0.5 mg q.h.s.) may also be effective for acne by suppressing ...

Dexamethasone was administered intravenously at a dosage of 0.3–0.5 mg/kg/day over 0.5–1 h for 5 consecutive ... The ages of the patients ranged from 1 to 16 years, with an average age of 6.8 years.

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Ivarmacitinib at both 4 mg and 8 mg doses was found to be efficacious in treating alopecia areata in a phase 3 trial.

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...

Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...

Atishay Ltd has secured a significant new work order from The Udaipur Central Cooperative Bank Ltd., Udaipur, Rajasthan.

Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...